U-radiomics for predicting survival of patients with idiopathic pulmonary fibrosis

被引:1
|
作者
Uemura, Tomoki [1 ,2 ,3 ]
Watari, Chinatsu [1 ,2 ]
Nappi, Janne J. [1 ,2 ]
Hironaka, Toru [1 ,2 ]
Kim, Hyoungseop [3 ]
Yoshida, Hiroyuki [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiol, 3D Imaging Res, 25 New Chardon St,Suite 400C, Boston, MA 02114 USA
[2] Harvard Med Sch, 25 New Chardon St,Suite 400C, Boston, MA 02114 USA
[3] Kyushu Inst Technol, Dept Mech & Control Engn, 1-1 Sensui Cho, Kitakyushu, Fukuoka 8048550, Japan
关键词
radiomics; deep learning; U-Net; survival analysis; idiopathic pulmonary fibrosis; interstitial lung diseases; USUAL INTERSTITIAL PNEUMONIA; INDEX;
D O I
10.1117/12.2551273
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We developed and evaluated the effect of U-Net-based radiomic features, called U-radiomics, on the prediction of the overall survival of patients with idiopathic pulmonary fibrosis (IPF). To generate the U-radiomics, we retrospectively collected lung CT images of 72 patients with interstitial lung diseases. An experienced observer delineated regions of interest (ROIs) from the lung regions on the CT images and labeled them into one of four interstitial lung disease patterns (ground-glass opacity, reticulation, consolidation, and honeycombing) or a normal pattern. A U-Net was trained on these images for classifying the ROIs into one of the above five lung tissue patterns. The trained U-Net was applied to the lung CT images of an independent test set of 75 patients with IPF, and a U-radiomics vector for each patient was identified as the mean of the bottleneck layer of the U-Net across all the CT images of the patient. The U-radiomics vector was subjected to a Cox proportional hazards model with an elastic-net penalty for predicting the survival of the patient. The evaluation was performed by using bootstrapping with 500 replications, where the concordance index (C-index) was used as the comparative performance metric. The preliminary results showed the following C-index values for two clinical biomarkers and the U-radiomics: (a) composite physiologic index (CPI): 64.6%, (b) gender, age, and physiology (GAP) index: 65.5%, and (c) U-radiomics: 86.0%. The U-radiomics significantly outperformed the clinical biomarkers in predicting the survival of IPF patients, indicating that the U-radiomics provides a highly accurate prognostic biomarker for patients with IPF.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis
    Oldham, Justin M.
    Kumar, Disha
    Lee, Cathryn
    Patel, Shruti B.
    Takahashi-Manns, Stephenie
    Demchuk, Carley
    Strek, Mary E.
    Noth, Imre
    CHEST, 2015, 148 (03) : 692 - 700
  • [42] Survival and PFT Changes Post Transplant in Patients with Idiopathic Pulmonary Fibrosis
    Ramirez, A.
    Kashem, A.
    Kehara, H.
    Yanagida, R.
    Krishan, K.
    Leotta, E.
    Shigemura, N.
    Toyoda, Y.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S424 - S424
  • [43] Pulmonary rehabilitation improves survival in patients with idiopathic pulmonary fibrosis undergoing lung transplantation
    Florian, Juliessa
    Watte, Guilherme
    Zimermann Teixeira, Paulo Jose
    Altmayer, Stephan
    Schio, Sadi Marcelo
    Sanchez, Leticia Beatriz
    Nascimento, Douglas Zaione
    Camargo, Spencer Marcantonio
    Perin, Fabiola Adelia
    Camargo, Jose de Jesus
    Felicetti, Jose Carlos
    Moreira, Jose da Silva
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [44] Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone
    Donato Lacedonia
    Michele Correale
    Lucia Tricarico
    Giulia Scioscia
    Silvia Romana Stornelli
    Filomena Simone
    Massimo Casparrini
    Natale Daniele Brunetti
    Maria Pia Foschino Barbaro
    Internal and Emergency Medicine, 2022, 17 : 815 - 822
  • [45] The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis listed for lung transplant
    Shorr, Andrew F.
    Wainright, Jennifer
    Lettieri, Christopher
    Helman, Donald
    CHEST, 2007, 132 (04) : 428S - 428S
  • [46] Pulmonary rehabilitation improves survival in patients with idiopathic pulmonary fibrosis undergoing lung transplantation
    Juliessa Florian
    Guilherme Watte
    Paulo José Zimermann Teixeira
    Stephan Altmayer
    Sadi Marcelo Schio
    Letícia Beatriz Sanchez
    Douglas Zaione Nascimento
    Spencer Marcantonio Camargo
    Fabiola Adélia Perin
    José de Jesus Camargo
    José Carlos Felicetti
    José da Silva Moreira
    Scientific Reports, 9
  • [47] Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone
    Lacedonia, Donato
    Correale, Michele
    Tricarico, Lucia
    Scioscia, Giulia
    Stornelli, Silvia Romana
    Simone, Filomena
    Casparrini, Massimo
    Brunetti, Natale Daniele
    Barbaro, Maria Pia Foschino
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (03) : 815 - 822
  • [48] Antacid and patient survival in idiopathic pulmonary fibrosis
    Huh, Jin-Young
    Song, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [49] Proteomic Determinants of Idiopathic Pulmonary Fibrosis Survival
    Oldham, J.
    Huang, Y.
    Ma, S.
    Lee, C. T.
    Kim, J.
    Pugashetti, J. V.
    Mou, K.
    Schwab, A.
    Strek, M. E.
    Adegunsoye, A. O.
    Linderholm, A.
    Martinez, F. J.
    Noth, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [50] Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis
    Oldham, Justin M.
    Huang, Yong
    Bose, Swaraj
    Ma, Shwu-Fan
    Kim, John S.
    Schwab, Alexandra
    Ting, Christopher
    Mou, Kaniz
    Lee, Cathryn T.
    Adegunsoye, Ayodeji
    Ghodrati, Sahand
    Pugashetti, Janelle Vu
    Nazemi, Nazanin
    Strek, Mary E.
    Linderholm, Angela L.
    Chen, Ching-Hsien
    Murray, Susan
    Zemans, Rachel L.
    Flaherty, Kevin R.
    Martinez, Fernando J.
    Noth, Imre
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209 (09) : 1111 - 1120